CIPROFLOXACIN AS THERAPY FOR EXPERIMENTAL OSTEOMYELITIS CAUSED BY PSEUDOMONAS-AERUGINOSA

被引:78
作者
NORDEN, CW [1 ]
SHINNERS, E [1 ]
机构
[1] UNIV PITTSBURGH,SCH MED,PITTSBURGH,PA 15261
关键词
D O I
10.1093/infdis/151.2.291
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:291 / 294
页数:4
相关论文
共 6 条
[1]   INVITRO ACTIVITY OF CIPROFLOXACIN, A NEW CARBOXYQUINOLINE ANTIMICROBIAL AGENT [J].
ELIOPOULOS, GM ;
GARDELLA, A ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :331-335
[2]   ACTIVITIES OF TOBRAMYCIN AND AZLOCILLIN ALONE AND IN COMBINATION AGAINST EXPERIMENTAL OSTEOMYELITIS CAUSED BY PSEUDOMONAS-AERUGINOSA [J].
NORDEN, CW ;
SHAFFER, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :62-65
[3]   EXPERIMENTAL OSTEOMYELITIS CAUSED BY PSEUDOMONAS-AERUGINOSA [J].
NORDEN, CW ;
KELETI, E .
JOURNAL OF INFECTIOUS DISEASES, 1980, 141 (01) :71-75
[4]   EXPERIMENTAL OSTEOMYELITIS .4. THERAPEUTIC TRIALS WITH RIFAMPIN ALONE AND IN COMBINATION WITH GENTAMICIN, SISOMICIN, AND CEPHALOTHIN [J].
NORDEN, CW .
JOURNAL OF INFECTIOUS DISEASES, 1975, 132 (05) :493-499
[5]  
NORDEN CW, 1980, BRIT J EXP PATHOL, V61, P451
[6]   RESISTANCE TO NALIDIXIC-ACID - MISCONCEPTION DUE TO UNDER-DOSAGE [J].
STAMEY, TA ;
BRAGONJE, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 236 (16) :1857-1860